Search

Ross M Kedl

age ~54

from Centennial, CO

Get Report
Also known as:
  • Ross Anne Kedl
  • Ross M Keol
  • Ross M Keoll
Phone and address:
2351 Krameria St, Denver, CO 80222
303-756-0368
Related to:
Connected to:

Ross Kedl Phones & Addresses

  • 2351 Krameria St, Denver, CO 80222 • 303-756-0368
  • 5867 Long Ave, Centennial, CO 80112 • 303-221-0922
  • Lone Tree, CO
  • 969 Lydia Ave, Roseville, MN 55113 • 651-765-0723
  • Englewood, CO
  • Lone Tree, CO
  • 969 Lydia Dr W, Saint Paul, MN 55113

Work

  • Position:
    Building and Grounds Cleaning and Maintenance Occupations

Education

  • Degree:
    Graduate or professional degree
Name / Title
Company / Classification
Phones & Addresses
Ross Kedl
Owner
Ross M Kedl
Grant Reviewer
7524 S Cook Way, Littleton, CO 80122

Resumes

Ross Kedl Photo 1

Professor

view source
Location:
Denver, CO
Industry:
Research
Work:
University of Colorado Anschutz Medical Campus
Professor
University of Colorado Denver Business School
Professor
3M Health Care Jun 2001 - Jun 2004
Senior Immunologist
Education:
University of Minnesota 1993 - 1997
Doctorates, Doctor of Philosophy, Immunology University of Minnesota 1988 - 1992
Bachelors, Bachelor of Science, Biology
Skills:
Molecular Biology
Cell Biology
Science
Immunology
Cell Culture
Flow Cytometry
Animal Models
Lifesciences
Molecular Cloning
Cancer
Elisa
Western Blotting
Pcr
Cell
In Vivo
Ross Kedl Photo 2

Assistat Professor

view source
Location:
Denver, CO
Industry:
Research
Work:
University of Colorado
Assistat Professor
Ross Kedl Photo 3

Assistant Professor

view source
Location:
Denver, CO
Industry:
Research
Work:
University of Colorado
Assistant Professor
3M Health Care 2001 - 2004
Senior Immunologist
Education:
University of Minnesota 1993 - 1997
Doctorates, Doctor of Philosophy, Immunology

Us Patents

  • Immunostimulatory Combinations

    view source
  • US Patent:
    7387271, Jun 17, 2008
  • Filed:
    Dec 30, 2003
  • Appl. No.:
    10/748010
  • Inventors:
    Randolph J. Noelle - Plainfield NH, US
    Cory L. Ahonen - Hanover NH, US
    Ross M. Kedl - Roseville MN, US
  • Assignee:
    3M Innovative Properties Company - St. Paul MN
    Trustees of Dartmouth College - Hanover NH
  • International Classification:
    A61K 39/12
    A61K 39/02
    A61K 38/19
    A61K 39/395
    A61K 31/44
    A61K 31/435
    A61K 31/47
    C07K 14/715
  • US Classification:
    2422781, 4241441, 4241841, 4242041, 4242341, 4242651, 4242771, 514 2, 514 44, 514311, 514315
  • Abstract:
    The present invention provides immunostimulatory combinations. Generally, the immunostimulatory combinations include a TLR agonist and a TNF/R agonist. Certain immunostimulatory combinations also may include an antigen.

  • Immunostimulatory Compositions And Methods Of Stimulating An Immune Response

    view source
  • US Patent:
    7427629, Sep 23, 2008
  • Filed:
    Aug 14, 2003
  • Appl. No.:
    10/640904
  • Inventors:
    Ross M. Kedl - Roseville MN, US
    George W. Griesgraber - Eagan MN, US
    Isidro Angelo E. Zarraga - Minneapolis MN, US
    Paul D. Wightman - Woodbury MN, US
  • Assignee:
    3M Innovative Properties Company - Saint Paul MN
  • International Classification:
    A61K 31/44
  • US Classification:
    514279
  • Abstract:
    The present invention provides immunostimulatory compositions that include an immune response modifier portion paired with an antigenic portion.

  • Immunostimulatory Regimen Comprising Administering Type 1 Interferon And Agonistic Anti-Cd40 Antibody

    view source
  • US Patent:
    8137672, Mar 20, 2012
  • Filed:
    Jun 21, 2011
  • Appl. No.:
    13/165154
  • Inventors:
    Ross Kedl - Centennial CO, US
    Phillip J. Sanchez - Centennial CO, US
    Catherine Haluszczak - Centennial CO, US
  • Assignee:
    The Regents of the University of Colorado - Denver CO
  • International Classification:
    A61K 39/395
    A61K 38/19
    A61K 38/21
    A61K 35/76
  • US Classification:
    4241531, 424 854, 424 856, 4241431, 4241441, 4241731, 4241841, 4242041
  • Abstract:
    A synergistic adjuvant is provided comprising synergistically effective amounts of at least one type 1 interferon and at least one CD40 agonist, wherein these moieties may be in the same or separate compositions. In addition, fusion proteins and DNA conjugates which contain a type 1 interferon/CD40 agonist/antigen combination are provided. The use of these compositions, protein and DNA conjugates as immune adjuvants for treatment of various chronic diseases such as HIV infection and for enhancing the efficacy of vaccines (prophylactic and therapeutic) is also provided.

  • Ex Vivo Uses Of Immunostimulatory Combinations

    view source
  • US Patent:
    8329197, Dec 11, 2012
  • Filed:
    Jul 29, 2010
  • Appl. No.:
    12/845888
  • Inventors:
    Randolph J. Noelle - Plainfield NH, US
    Cory L. Ahonen - Hanover NH, US
    Ross M. Kedl - Roseville MN, US
  • Assignee:
    3M Innovative Properties Company - St. Paul MN
    Trustees of Dartmouth - Hanover NH
  • International Classification:
    A61K 39/00
    A61K 39/395
    A61K 31/44
    A61K 31/47
    A61K 38/19
    C07K 14/725
  • US Classification:
    4242781, 4241441, 4241841, 514 44 R, 514311, 514315, 514 11, 514 24, 514 37
  • Abstract:
    The present invention provides immunostimulatory combinations. Generally, the immunostimulatory combinations include a TLR agonist and a TNF/R agonist. Certain immunostimulatory combinations also may include an antigen.

  • Immunostimulatory Regimen Comprising Administering Type 1 Interferon And Agonistic Anti-Cd40 Antibody

    view source
  • US Patent:
    8361471, Jan 29, 2013
  • Filed:
    Jul 29, 2010
  • Appl. No.:
    12/846232
  • Inventors:
    Ross Kedl - Centennial CO, US
    Phillip J. Sanchez - Centennial CO, US
    Catherine Haluszczak - Centennial CO, US
  • Assignee:
    The Regents of the University of Colorado - Denver CO
  • International Classification:
    A61K 39/395
    A61K 38/19
    A61K 38/21
    A61K 39/00
  • US Classification:
    4241531, 424 854, 424 856, 424 857, 4241431, 4241441, 4241731, 4241841
  • Abstract:
    A synergistic adjuvant is provided comprising synergistically effective amounts of at least one type 1 interferon and at least one CD40 agonist, wherein these moieties may be in the same or separate compositions. In addition, fusion proteins and DNA conjugates which contain a type 1 interferon/CD40 agonist/antigen combination are provided. The use of these compositions, protein and DNA conjugates as immune adjuvants for treatment of various chronic diseases such as HIV infection and for enhancing the efficacy of vaccines (prophylactic and therapeutic) is also provided.

  • Immunostimulatory Regimen Comprising Administering Type 1 Interferon And Agonistic Anti-Cd40 Antibody

    view source
  • US Patent:
    7993648, Aug 9, 2011
  • Filed:
    May 3, 2007
  • Appl. No.:
    11/743978
  • Inventors:
    Ross Kedl - Centennial CO, US
    Phillip J. Sanchez - Centennial CO, US
    Catherine Haluszczak - Centennial CO, US
  • Assignee:
    The Regents of the Universitry of Colorado - Denver CO
  • International Classification:
    A61K 39/395
    A61K 38/19
    A61K 38/21
  • US Classification:
    4241531, 424 854, 424 856, 424 857, 4241431, 4241441, 4241731
  • Abstract:
    A synergistic adjuvant is provided comprising synergistically effective amounts of at least one type 1 interferon and at least one CD40 agonist, wherein these moieties may be in the same or separate compositions. In addition, fusion proteins and DNA conjugates which contain a type 1 interferon/CD40 agonist/antigen combination are provided. The use of these compositions, protein and DNA conjugates as immune adjuvants for treatment of various chronic diseases such as HIV infection and for enhancing the efficacy of vaccines (prophylactic and therapeutic) is also provided.

  • Tlr9 Agonist And Cd40 Agonist Immunostimulatory Combinations

    view source
  • US Patent:
    7993659, Aug 9, 2011
  • Filed:
    Mar 17, 2008
  • Appl. No.:
    12/049874
  • Inventors:
    Randolph J. Noelle - Plainfield NH, US
    Cory L. Ahonen - Hanover NH, US
    Ross M. Kedl - Roseville MN, US
  • Assignee:
    3M Innovative Properties Company - St. Paul MN
    Trustees of Dartmouth College - Hanover NH
  • International Classification:
    A61K 39/02
    A61K 39/12
    A61K 38/19
    A61K 39/395
    A61K 31/44
    A61K 31/435
    A61K 31/47
    C12N 15/10
  • US Classification:
    4242781, 4241441, 4241841, 4242041, 4242341, 4242651, 4242741, 4242771, 514311, 514315, 514 44 R
  • Abstract:
    The present invention provides immunostimulatory combinations. Generally, the immunostimulatory combinations include a TLR agonist and a TNF/R agonist. Certain immunostimulatory combinations also may include an antigen.

  • Methods And Compositions For Enhancing Immune Response

    view source
  • US Patent:
    20040265351, Dec 30, 2004
  • Filed:
    Apr 9, 2004
  • Appl. No.:
    10/821330
  • Inventors:
    Richard Miller - Maplewood MN, US
    Mark Tomai - Woodbury MN, US
    Ross Kedl - Denver CO, US
    Isidro Zarraga - Minneapolis MN, US
    Ronnie Ortiz - Apple Valley MN, US
    James Stoesz - Inver Grove Heights MN, US
  • International Classification:
    A61K031/44
  • US Classification:
    424/423000
  • Abstract:
    Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region.

Facebook

Ross Kedl Photo 4

Ross M. Kedl

view source
Get Report for Ross M Kedl from Centennial, CO, age ~54
Control profile